BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16875736)

  • 21. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of nitric oxide synthase 3 on myocardial dysfunction in sepsis].
    Ichinose F
    Masui; 2008 Mar; 57(3):294-301. PubMed ID: 18340997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac dysfunction in heart failure: the cardiologist's love affair with time.
    Brutsaert DL
    Prog Cardiovasc Dis; 2006; 49(3):157-81. PubMed ID: 17084177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model of myocardial inflammation and dysfunction in burn complicated by sepsis.
    Horton JW
    Shock; 2007 Sep; 28(3):326-33. PubMed ID: 17529909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of immune dysfunction in determining outcome in acute liver failure.
    Antoniades CG; Berry PA; Wendon JA; Vergani D
    J Hepatol; 2008 Nov; 49(5):845-61. PubMed ID: 18801592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B-type natriuretic peptide: a biomarker for the diagnosis and risk stratification of patients with septic shock.
    Kandil E; Burack J; Sawas A; Bibawy H; Schwartzman A; Zenilman ME; Bluth MH
    Arch Surg; 2008 Mar; 143(3):242-6; discussion 246. PubMed ID: 18347270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytochrome P450 activity mirrors nitric oxide levels in postoperative sepsis: predictive indicators of lethal outcome.
    Novotny AR; Emmanuel K; Maier S; Westerholt A; Weighardt H; Stadler J; Bartels H; Schwaiger M; Siewert JR; Holzmann B; Heidecke CD
    Surgery; 2007 Mar; 141(3):376-84. PubMed ID: 17349850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Blockers in sepsis: reexamining the evidence.
    Novotny NM; Lahm T; Markel TA; Crisostomo PR; Wang M; Wang Y; Ray R; Tan J; Al-Azzawi D; Meldrum DR
    Shock; 2009 Feb; 31(2):113-9. PubMed ID: 18636043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated protein C: controversy and hope in the treatment of sepsis.
    Baillie JK
    Curr Opin Investig Drugs; 2007 Nov; 8(11):933-8. PubMed ID: 17979027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on sepsis: pathophysiology and treatment.
    Vincent JL
    Acta Clin Belg; 2000; 55(2):79-87. PubMed ID: 10881372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of neutrophils in severe sepsis.
    Alves-Filho JC; de Freitas A; Spiller F; Souto FO; Cunha FQ
    Shock; 2008 Oct; 30 Suppl 1():3-9. PubMed ID: 18704017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heart failure--new insights.
    Blum A
    Isr Med Assoc J; 2009 Feb; 11(2):105-11. PubMed ID: 19432040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High C5a levels are associated with increased mortality in sepsis patients--no enhancing effect by actin-free Gc-globulin.
    Gressner OA; Koch A; Sanson E; Trautwein C; Tacke F
    Clin Biochem; 2008 Aug; 41(12):974-80. PubMed ID: 18538666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ dysfunction in patients with severe sepsis.
    Vincent JL
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S69-72. PubMed ID: 16895511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rheumatoid arthritis and the complement system.
    Okroj M; HeinegÄrd D; Holmdahl R; Blom AM
    Ann Med; 2007; 39(7):517-30. PubMed ID: 17852027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism modulators in sepsis: the abnormal pituitary response.
    Maxime V; Siami S; Annane D
    Crit Care Med; 2007 Sep; 35(9 Suppl):S596-601. PubMed ID: 17713415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?].
    Karima R
    Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Septic shock and NO].
    Ichinose F
    Masui; 2006 Nov; 55 Suppl():S18-23. PubMed ID: 17458113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.